Healthcare Quality & Analytics Intern
About the job
- The candidate must be currently enrolled in an undergraduate program, be a freshman or sophomore, and have a minimum GPA of 3.0.
- The candidate must be able to commit to the full-time, 10-week internship program.
- The candidate must possess unrestricted authorization to work in the United States.
- The candidate must have clear and professional written, verbal, and interpersonal communication skills.
- The candidate must have a strong work ethic, be self-motivated, and be able to develop relationships.
- The candidate must have good time management, organizational, and interpersonal skills.
- The candidate must have computer experience, including Microsoft Word, Excel, Outlook, and PowerPoint, and experience with internet research.
- The candidate must have critical thinking and problem-solving skills.
- The candidate must be able to handle confidential information and maintain confidentiality while complying with the Health Insurance Portability and Accountability Act (HIPAA).
- Learn how healthcare quality impacts the Medicaid customers served in Wisconsin.
- Learn about Population Health Management, Health Equity, and Quality Improvement concepts and their intersection with healthcare, business, and quality.
- Learn and apply the Institute for Healthcare Improvement Model of Quality Improvement (Plan-Do-Study-Act) to improve health outcomes for the Medicaid population.
- Work closely with the Quality Improvement Provider Engagement, Quality Analytics, Quality Intervention, and Quality Compliance teams and their leadership.
- Lead and assist with executing member- and provider-facing Quality Improvement interventions.
- Study the effectiveness of member- and provider-facing Quality Improvement interventions.
- Support Health Equity analytics and decision-making.
JOB DESCRIPTION
JOB SUMMARY (Purpose of the Job & high-level summary):
The Molina Healthcare Internship Program shares an objective to create a steppingstone for students who aim to be professionals and future leaders in the healthcare business profession. Interns are assigned special projects and various other duties that are intended to provide them with valuable professional work experience and industry insight. The purpose of an internship is to develop talent by providing students with experiential learning, formal training and opportunities to interact with healthcare professionals and community leaders. Interns will perform meaningful work alongside talented professionals, gaining insight to Molina’s culture, Mission and Values.
KNOWLEDGE, SKILLS & ABILITIES
Quality Improvement (QI) – WI Medicaid
Preferred Experience
REQUIRED EDUCATION:
Salary Range: $9.25 - $18.05 Hourly *Actual compensation may vary based on geographic location, work experience, education and/or skill level
About the company
Molina Healthcare runs health insurance plans for people covered by Medicaid, Medicare and state insurance marketplaces, with a focus on people who need affordable access to care. Its local health plans coordinate medical services and support members with complex health needs, including people eligible for both Medicaid and Medicare. Members receive care through networks of doctors, hospitals and other providers, while the plans manage benefits, process claims and arrange care support. The company earns premiums from government programs and members, and pays the cost of covered healthcare services. Molina was founded in 1980 and is headquartered in Long Beach, California.
Company Size
10,001+
Company Stage
IPO
Headquarters
Long Beach, California
Founded
1980
Get referred to Molina Healthcare
See people who can refer or advise you
Simplify's Take
What believers are saying
- Illinois continuity gained ground: June 2026 brought an intended Molina Medicaid contract award for four-and-a-half years.
- Recovery has a higher target: Molina raised adjusted earnings guidance to $5.25 per share in July 2026.
- Career development has a named route: Molina's Pathways to Success helps staff navigate careers across the organization.
What critics are saying
- Profits remain under pressure: Molina reported a 76% quarterly net income decline in July 2026.
- Margins are fragile: Molina estimates one additional medical spending percentage point cuts 2025 earnings per share by $6.20.
- Remote still means travel: Molina's California site review nurse role requires field visits three to four days weekly.
What makes Molina Healthcare unique
- Pharmacy work goes outside: Molina outsources drug benefits administration to CVS Caremark.
- Wisconsin work includes long-term care: Molina's My Choice Wisconsin runs Family Care and Partnership programs.
- Connecticut retains a local brand: Molina owns ConnectiCare, a health plan focused on the state.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Paid Vacation
- Flexible Work Hours
- Wellness Program
- Mental Health Support
- Conference Attendance Budget
- Professional Development Budget
- Phone/Internet Stipend
- Home Office Stipend
- Family Planning Benefits
Company News
Molina Healthcare (NYSE:MOH) stock gets price target boost from JPMorgan Chase & Co. October 27, 2026 Key points. * JPMorgan raised Molina Healthcare's price target to $225 from $220 while maintaining a "neutral" rating, implying roughly 13.8% upside from the reported share price. * Analyst sentiment remains cautious: Molina has a consensus "Hold" rating and an average price target of $213.88, with 13 Hold, three Buy and two Sell ratings. * Molina exceeded quarterly expectations with adjusted EPS of $0.89 versus a $0.79 consensus and revenue of $11.08 billion, although revenue declined 3.4% year over year and earnings fell from $1.84 per share. * Tracking Molina Healthcare through earnings season? MarketBeat All Access sends real-time alerts on ratings, earnings, and news - $149 a year, locked in for as long as you stay. Molina Healthcare (NYSE:MOH - Get Free Report) had its price target raised by analysts at JPMorgan Chase & Co. from $220.00 to $225.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price objective points to a potential upside of 13.78% from the stock's current price. Several other equities analysts have also issued reports on the stock. Royal Bank Of Canada boosted their price target on shares of Molina Healthcare from $218.00 to $222.00 and gave the company a "sector perform" rating in a report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $163.00 price objective on shares of Molina Healthcare in a research note on Monday. UBS Group lifted their target price on Molina Healthcare from $202.00 to $225.00 and gave the stock a "neutral" rating in a report on Friday. Cantor Fitzgerald reissued a "neutral" rating on shares of Molina Healthcare in a research note on Friday, October 9th. Finally, Weiss Ratings upgraded Molina Healthcare from a "sell (d)" rating to a "sell (d+)" rating in a report on Wednesday, October 21st. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Molina Healthcare has a consensus rating of "Hold" and an average price target of $213.88. Molina Healthcare price performance. Shares of Molina Healthcare stock traded down $7.04 during midday trading on Tuesday, hitting $197.75. 448,026 shares of the company were exchanged, compared to its average volume of 1,279,888. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market cap of $10.32 billion, a P/E ratio of -205.61, a PEG ratio of 29.89 and a beta of 0.78. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $244.89. The firm has a 50 day simple moving average of $200.74 and a 200-day simple moving average of $184.42. Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The business's revenue for the quarter was down 3.4% on a year-over-year basis. Research analysts forecast that Molina Healthcare will post 5.30 earnings per share for the current year. Institutional trading of Molina Healthcare. Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in Molina Healthcare during the 2nd quarter worth approximately $1,503,052,000. Wellington Management Group LLP raised its stake in shares of Molina Healthcare by 11.9% during the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company's stock valued at $289,810,000 after acquiring an additional 135,247 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company's stock worth $185,929,000 after purchasing an additional 267,121 shares during the period. Manning & Napier Advisors LLC acquired a new position in shares of Molina Healthcare during the second quarter worth $152,339,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Molina Healthcare during the second quarter worth $86,138,000. 98.50% of the stock is currently owned by institutional investors. About Molina Healthcare. Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act. The company's services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Molina Healthcare, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list. While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow. Continue following MarketBeat
Elevance, Molina see Medicaid margins turning in 2027. Two of the largest Medicaid managed care insurers told investors last week that the margin pressure squeezing the business since redeterminations resumed may be easing, though their third-quarter results show the recovery has not yet reached the bottom line. Molina Healthcare's net income fell 52 percent to $38 million while its Medicaid medical care ratio rose to 93 percent, according to the company's third-quarter results. "Medicaid is moving from stabilization to improvement," Elevance Health CEO Gail Boudreaux said on her company's Oct. 21 earnings call, citing better rate alignment and greater visibility, according to published reports. Molina President and CEO Joseph Zubretsky said his company believes it is "likely observing the beginning of the turn in Medicaid margins." What the Medicaid margins data shows. The quarter's numbers describe a business still under pressure rather than one recovering. At Molina: * Premium revenue fell 4 percent to about $10.5 billion, as lower Medicaid and Marketplace membership offset rate updates * The Medicaid medical care ratio rose to 93 percent from 92 percent a year earlier, which the company said matched its expectations * Medicaid membership fell to 4.37 million from 4.64 million * Adjusted net income fell 53 percent to $46 million Elevance fared better overall, though not because of Medicaid. Net income rose 13.1 percent to $1.34 billion on operating revenue of $50.4 billion, and its benefit expense ratio improved 70 basis points to 90.6 percent, which the company attributed mainly to Medicare Advantage and individual ACA performance. Elevance's Medicaid membership stood at 8.22 million at Sept. 30, down 4.9 percent year over year and 1.7 percent from June. Medicaid operating revenue nonetheless rose 5.7 percent to $14.98 billion, reflecting rate increases on a smaller membership base. Why executives expect a turn. The case for improvement rests on rates catching up to costs. Zubretsky said medical cost trend appears to be plateauing at elevated levels, and that rate increases should correct the imbalance that opened when states set rates using data from a healthier pre-redetermination population. Molina Chief Financial Officer Mark Keim told investors that six states the company serves have factored the reconciliation law's Medicaid work requirements and more frequent redeterminations into rate adjustments, according to published reports. He projected modest growth in the Medicaid segment for 2027, with rate increases offsetting expected member attrition, and stronger growth in dual-eligible products tied to program changes in Ohio, Texas and California. Elevance CFO Mark Kaye said he expects Medicaid margins to improve in 2027. The company has maintained a full-year 2026 Medicaid operating margin forecast of about negative 1.75 percent, describing this year as the trough. The retrenchment continues. Optimism about 2027 has not stopped either insurer from exiting markets. Elevance's Wellpoint left the District of Columbia managed care program in August by mutual agreement with the city's Department of Health Care Finance, followed by 85 job cuts, and executives have signaled further pullbacks. Molina reported delays with new Medicaid contracts in Georgia and Texas. Its 2026 guidance includes a $1.50 per-share loss from its new Florida Medicaid contract in the fourth quarter, though the company expects that contract to break even or better on a full-year basis in 2027. Molina is also exiting its traditional Medicare Advantage prescription drug product for 2027, a decision carrying a $1.00 per-share loss this year. Molina reaffirmed 2026 guidance of about $42 billion in premium revenue and at least $5.25 in adjusted earnings per share. Elevance raised its full-year outlook to at least $29.00 in adjusted diluted EPS. What could undo the forecast. Several factors could prevent the predicted recovery: * Work requirements taking effect in 2027 will remove members, and if those leaving are healthier than those remaining, acuity rises again regardless of rate increases * State budgets are absorbing federal cuts, which limits how generous rate-setting can be * Rate adequacy is determined state by state, so a national margin forecast averages markets that may diverge * Executives forecasting improvement are the same ones who described 2026 as a trough, a characterization made before the quarter's results What it means for states and providers. For state Medicaid agencies, insurer commentary that rates are becoming adequate is a negotiating signal worth noting: plans publicly describing 2027 rates as sufficient have limited room to argue the opposite in the next procurement. For providers, continued membership decline matters more than insurer margins. Molina and Elevance together cover roughly 12.6 million Medicaid members, down from about 13.3 million a year earlier, and those departures appear in provider revenue as uninsured or self-pay encounters before they appear in any insurer's earnings.
Molina Healthcare reported third-quarter revenue of $11.08 billion, down 3.4% year on year but 2% above analyst estimates of $10.87 billion. Adjusted earnings per share were $0.89, beating the $0.79 forecast by 12%. Chief executive officer Joe Zubretsky called the quarter's Medicaid pre-tax margin a "trough" in a multi-year cycle. He said recent rate updates helped offset higher medical costs. Customers fell to 4.86 million from 4.93 million in the previous quarter. Molina reiterated full-year adjusted EPS guidance of $5.25 at the midpoint. On the earnings call, chief financial officer Mark Keim said Medicaid work requirements should cut membership by about 6% in 2027, with further losses in 2028 and 2029. Molina's market capitalisation is $11.29 billion. Its shares trade at $213.60.
Molina's membership decline cuts into quarterly profit. Molina Healthcare's lower Medicaid and Marketplace membership weighed on quarterly earnings, putting enrollment stability and cost flexibility in focus. Molina Healthcare reported third-quarter profit of $38 million, down from $79 million a year earlier, with lower Medicaid and Marketplace membership weighing on results. Molina Healthcare (MOH; exchange not identified in the supplied market data) reported third-quarter profit of $38 million, down from $79 million a year earlier, as lower membership in Medicaid and Marketplace weighed on results. Revenue also declined, putting the scale of its enrollment business at the center of the earnings story. The result leaves investors with a question that goes beyond the headline profit decline: can Molina stabilize its membership while keeping the cost of serving those members aligned with the revenue they generate? For a health insurer, losing enrollment can reduce both premium income and medical obligations, but those changes do not necessarily arrive together or offset each other. The profit figures and the impact of lower membership were reported by WSJ US Business. The available results establish the direction of the business, but do not quantify the membership decline or separate the earnings impact of Medicaid from Marketplace. Enrollment losses put the revenue base under pressure. Membership is a central driver of a health insurer's business because it determines the population for which the company receives premiums and assumes responsibility for covered care. Fewer members generally mean a smaller base of premium revenue. Molina's lower revenue is consistent with that pressure, although the available facts do not establish how much of the revenue decline came from enrollment rather than other factors. Medicaid and Marketplace also represent distinct coverage channels. Medicaid provides public health coverage to eligible people, while Marketplace plans are sold through health insurance exchanges. A decline across these channels can affect an insurer differently depending on which members leave, the premiums associated with their coverage and their medical needs. That makes the composition of Molina's membership losses important. A smaller book of business is not automatically a less profitable one, just as enrollment growth does not automatically produce better earnings. The financial outcome depends on the relationship between revenue, claims and the expenses required to operate the plans. The available information does not show whether enrollment fell because of eligibility changes, customer choices, contract developments or other causes. Assigning the decline to any particular policy or competitive event would go beyond the evidence. What is clear is that lower membership affected the quarter's profit. Lower profit raises questions about cost flexibility. The decline to $38 million from $79 million makes cost adjustment an important part of the follow-up analysis. Health insurers pay medical claims, but they also maintain administrative operations, technology systems and services for members and providers. Some expenses can respond to enrollment changes more readily than others. If premium revenue falls while operating expenses take longer to adjust, profitability can come under pressure. That is a general business risk rather than an established explanation for Molina's entire earnings decline. The supplied results do not include an expense breakdown that would allow investors to measure how much administrative costs contributed. Medical spending is another essential part of the assessment. Losing members does not reveal whether the remaining membership is more or less costly to cover. Changes in the mix of members can alter the relationship between premiums collected and claims paid, even when total enrollment is moving lower. Losing members does not reveal whether the remaining membership is more or less costly to cover. For that reason, the profit decline should not be treated as a complete diagnosis of the business. It identifies weaker earnings, but not the relative contribution of enrollment, medical costs, pricing or administrative spending. Those distinctions matter because each would call for a different response and carry a different path toward improvement. The stock's closing decline is not a results verdict. The supplied market snapshot shows MOH finished down 2.19% at its most recent close, with the last trade recorded at 20:00 GMT on October 21, 2026. The market was closed at that timestamp. The snapshot does not establish that the move was a reaction to the quarterly results. That distinction matters when evaluating an earnings story. A closing share-price change records what happened during the trading session; it does not, by itself, explain why investors bought or sold. Without a verified sequence connecting the results to trading, the decline should remain market context rather than evidence of a specific earnings response. The fundamental question is separate from that daily move. Investors need to determine whether lower enrollment represents a temporary adjustment or a more persistent reduction in Molina's earnings base. The available figures do not resolve that question, and a share-price movement cannot substitute for the missing operating detail. Enrollment detail and the outlook are the next tests. The most useful additional disclosure would separate Medicaid and Marketplace membership trends and connect them to revenue and costs. That would help investors distinguish a volume problem from a profitability problem within the remaining business. It would also clarify whether pressure is concentrated in a particular coverage channel or spread more broadly. Management's outlook would provide another important check, but no forecast or management commentary is included in the supplied facts. There is therefore no basis here to describe an expected recovery, a further deterioration or a change in guidance. Those remain questions to investigate rather than conclusions from this quarter. For members and healthcare providers, lower insurer enrollment alone does not establish a change in benefits, access or payment arrangements. The reported result is a financial development, not evidence of a specific operational change affecting care. Any such implications would require separate disclosures. Molina's immediate challenge is clear even without those details: a smaller membership base has weighed on earnings, and revenue has moved lower alongside profit. Evidence that enrollment is stabilizing, combined with a clearer account of medical and administrative costs, would make the next assessment more useful than the headline profit figure alone. Key facts. * Third-quarter profit: $38 million, compared with $79 million a year earlier. * Revenue direction: Third-quarter revenue declined; no revenue total was supplied. * Membership pressure: Lower Medicaid and Marketplace membership weighed on profit. * MOH market snapshot: Most recent close: 214.90 (currency unspecified), down 2.19%; last trade October 21, 2026, at 20:00 GMT. Exchange not supplied. Frequently asked questions. How much profit did Molina Healthcare report? Molina Healthcare reported third-quarter profit of $38 million, compared with $79 million a year earlier. Revenue also declined. Lower membership in Medicaid and Marketplace weighed on profit, although the available information does not quantify the separate contribution of each coverage channel to the earnings decline. Why does lower membership matter for Molina? Membership determines the population for which Molina receives premiums and assumes responsibility for covered care. Fewer members can reduce premium revenue, but the effect on profit also depends on medical claims and operating expenses. Molina's results identify lower Medicaid and Marketplace membership as a factor weighing on quarterly profit. How much did Medicaid and Marketplace enrollment fall? The supplied results do not provide membership totals or quantify the decline in either Medicaid or Marketplace. They establish only that lower membership in those channels affected profit. Separate enrollment figures would be needed to assess the scale, concentration and potential persistence of the pressure on Molina's business. Did Molina's stock fall in response to the earnings report? The supplied market data show MOH closed down 2.19%, with its last trade recorded at 20:00 GMT on October 21, 2026. That snapshot does not establish a connection between the trading decline and the earnings report. It should be treated as market context, not a verified reaction to the results. Did Molina provide an updated earnings outlook? No earnings forecast or management outlook is included in the supplied information. It would therefore be unsupported to describe a guidance increase, reduction or reaffirmation. Investors assessing the next phase of the business would benefit from management's expectations for membership, medical spending and the adjustment of operating costs. What should investors examine next? Investors should look for separate Medicaid and Marketplace enrollment trends, the relationship between premiums and medical claims, and how administrative expenses respond to lower membership. Those disclosures would help explain whether weaker profit primarily reflects a smaller revenue base, changes in the remaining membership or costs that have not adjusted.
Molina Healthcare reported third-quarter 2026 revenue of $11.08 billion, down 3.4% year on year but 2% above analyst estimates of $10.87 billion. Adjusted earnings per share were $0.89, 12% above the $0.79 consensus, though down from $1.84 a year earlier. The healthcare insurer reiterated full-year adjusted earnings per share guidance of at least $5.25. Customers fell to 4.86 million from 4.93 million in the previous quarter, and free cash flow was -$196 million. "With the apparent plateauing of medical cost trend, which remains at elevated levels, and the strength of recent rate updates for 2027, we believe we are likely observing the beginning of the turn in Medicaid margins," said chief executive officer Joseph Zubretsky. The stock fell 4.1% to $206.08 after the results.